Clinical Trials · NCT06422624
A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
- Phase
- Phase 1
- Recruitment status
- Unknown
- Sponsor
- Bostal Drug Delivery Co., Ltd
- Enrollment
- 14
- Start date
- Aug 2024
- Locations
- See registry
- Primary endpoint
- Cmax